Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $7.0300 (0.72%) ($6.9300 - $7.0800) on Wed. Aug. 31, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.19% (three month average) | RSI | 55 | Latest Price | $7.0300(0.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN advances 0.4% a day on average for past five trading days. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IPO(6%) EWG(5%) IBUY(4%) TBT(4%) URA(4%) | Factors Impacting CGEN price | CGEN will decline at least -1.095% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-7%) TIP(-7%) BNDX(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.095% (StdDev 2.19%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
5 Day Moving Average | $6.9(1.88%) | 10 Day Moving Average | $6.95(1.15%) | 20 Day Moving Average | $6.88(2.18%) | To recent high | -3.2% | To recent low | 11.6% | Market Cap | $581m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |